Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Cryopreservation in cell therapy: Reducing variability from the start
2+ hour, 19+ min ago (774+ words) Cell therapies are among the most complex treatment modalities currently moving through clinical development, and much of that complexity sits in the supply chain. From patient cell collection to manufacturing and delivery, every operational decision can affect consistency, scalability, and…...
One of Europe's most advanced biotech campuses is in Marburg — and it's looking for pioneers
2+ week, 2+ hour ago (375+ words) Since COVID-19, the next pandemic is no longer abstract, and preparedness is no longer optional. Europe is investing heavily in infrastructure, expertise, and ecosystems that can respond quickly. That is why Marburg, Germany, has emerged as one of the continent’s…...
Why Customer Experience Centers are becoming practical infrastructure for life sciences innovation in Europe
4+ week, 2+ hour ago (434+ words) To address this need, a more hands-on, implementation-oriented model is gaining prominence across Europe’s life sciences landscape: the Customer Experience Center (CEC). The rise of CECs in Europe is a direct response to several structural gaps in the current biotech…...
Viral vector production: How CDMOs influence late-stage development success
1+ mon, 2+ week ago (471+ words) “By the time you’re in the late phase, there’s no room for error. A single misstep can unravel months or years of progress, triggering costly rework that may go all the way back to toxicology studies.” A failed batch, regulatory…...
Pharma in Spain: why global investors and innovators are moving in
1+ mon, 4+ week ago (287+ words) A shift in the European pharma sector’s center of gravity might be underway as Spain continues to build on its reputation for innovative biotechnology and life science. Innovation in biotechnology and in the pharma industry does not happen in a…...
Reducing cell culture contamination: Why sterilisation validation matters in CO₂ shaking workflows
2+ mon, 2+ week ago (230+ words) Cell culture contamination rarely announces itself. It often appears weeks later, through a subtle shift in cell behaviour, an unexpected assay result, or a failed experiment that forces a team to question every step of the workflow. For laboratories running…...
Biosimilars: a vital remedy for Europe’s healthcare challenges
8+ mon, 3+ week ago (243+ words) Since the first biosimilar approval in Europe twenty years ago, biosimilars have provided 6.9 billion patient treatment days and now provide 12% of the total volume of biologic treatments in Europe. The real-world impact behind these numbers is transformative. With chronic conditions,…...
Advancements in antimalarial drug discovery and development
11+ mon, 1+ week ago (143+ words) Explore innovations in antimalarial drug discovery, from screening and compound design to resistance mechanisms and PK optimization. Advancements in antimalarial drug discovery and development Explore innovations in antimalarial drug discovery, from screening and compound design to resistance mechanisms and PK…...